The worldwide burden of disease of bacterial meningitis remains high, despite the decreasing incidence following introduction of routine vaccination campaigns.
The aim of our study was to evaluate the epidemiological and bacteriological profile of paediatric bacterial meningitis (BM) in Tunisian children, during the period 2003–2019, following the implementation of Haemophilus influenzae type b (Hib) vaccine (April 2011) and before 10-valent pneumoccocal conjugate vaccine (PCV10) introduction to the childhood immunization program.
All bacteriologically confirmed cases of BM admitted to children's hospital of Tunis were recorded (January 2003 to April 2019). Serogroups of Neisseria meningitidis (Nm) and serotypes of Streptococcus pneumoniae (Sp) and H. influenzae (Hi) and antibiotic resistance were determined using conventional and molecular methods.
Among 388 cases, the most frequent species were Sp (51.3%), followed by Nm (27.5%) and Hi (16.8%). We observed a significant decrease in Hi BM rate during the conjugated Hib vaccine use period (P < 0.0001). The main pneumococcal serotypes were 14, 19F, 6B, 23F and 19A and the serotype coverage of PCV10, PCV13, PCV15 and PCV20 was 71.3 and 78.8%, 79.4 and 81.9% respectively. The most frequent Nm serogroup was B (83.1%). Most Hi strains were of serotype b (86.9%). High levels of resistance were found: Sp and Nm to penicillin (respectively 60.1 and 80%) and Hi to ampicillin (42.6%). All meningococcal and Hi isolates were susceptible to third-generation cephalosporins and 7.2% of pneumococcal strains had decreased susceptibility to these antibiotics.
The Hib conjugate vaccine decreased the rate of BM. Sp dominated the aetiology of BM in children in Tunisia. Conjugate vaccines introducing decreases not only BM cases but also antimicrobial resistance.
World Health Organization. Defeating meningitis by 2030: a global road map. World Health Organization; 2021. https://www.who.int/publications/i/item/9789240026407.
World Health Organization & Centers for Disease Control and Prevention (U.S.). Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO manual. 2nd ed. World Health Organization; 2011. https://apps.who.int/iris/handle/10665/70765.
Smaoui H, Tali-Maamar H, Zouhair S, Bouheraoua S, Mefteh K, Bouskraoui M, et al. Implementation of a prospective study for enhancing surveillance of invasive bacterial infections in North Africa. Int J Infect Dis 2022; 115: 101–5. https://pubmed.ncbi.nlm.nih.gov/34843957/.
Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337(14): 970–6. https://pubmed.ncbi.nlm.nih.gov/9395430/.
Slack MPE, Azzopardi HJ, Hargreaves RM, Ramsay ME. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines. Pediatr Infect Dis J 1998; 17(9 SUPPL.): S204–7. https://pubmed.ncbi.nlm.nih.gov/9781764/.
McIntyre PB, O’Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet 2012; 380(9854): 1703–11. https://pubmed.ncbi.nlm.nih.gov/23141619/.
Tin Tin Htar M, Madhava H, Balmer P, Christopoulou D, Menegas D, Bonnet E. A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis. Adv Ther 2013; 30(8): 748–62. https://pubmed.ncbi.nlm.nih.gov/24000099/.
Levy C, Varon E, Picard C, Béchet S, Martinot A, Bonacorsi S, et al. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J 2014; 33(12): 1216–21. https://pubmed.ncbi.nlm.nih.gov/25037044/.
Thabet L, Bousseta K, Kaabachi O, Smaoui H, Kechrid A. Bacteriological profile of bacterial meningitis in the Tunis children hospital. Med Mal Infect 2002; 32(1): 1–7. https://www.sciencedirect.com/science/article/pii/S0399077X01003067.
Mezghani S, Kassis M, Mahjoubi rhimi F, Damak J, Hammami A. Bacteriology of community acquired meningitis in Sfax, Tunisia. Med Mal Infect 2006; 36(2): 105–10. https://pubmed.ncbi.nlm.nih.gov/16459040/.
Sfaihi L, Kamoun F, Kamoun T, Aloulou H, Mezghani S, Hammemi A, et al. Bacterial meningitis in children: epidemiological data and outcome. Tunis Med 2014; 92(2): 141–6. https://pubmed.ncbi.nlm.nih.gov/24938236/.
Shinjoh M, Iwata S, Yagihashi T, Sato Y, Akita H, Takahashi T, et al. Recent trends in pediatric bacterial meningitis in Japan – a country where Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines have just been introduced. J Infect Chemother 2014; 20(8): 477–83. https://pubmed.ncbi.nlm.nih.gov/24855913/.
Taha MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 2000; 38(2): 855–7. https://pubmed.ncbi.nlm.nih.gov/10655397/.
Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 2001; 39(4): 1553–8. https://pubmed.ncbi.nlm.nih.gov/11283086/.
Haddad-Boubaker S, Lakhal M, Fathallah C, Bouafsoun A, Kharrat M, Khemiri M, et al. Molecular diagnosis of bacterial meningitis by multiplex real time PCR in Tunisian children. J Infect Dev Ctries 2018; 12(4): 235–43. https://pubmed.ncbi.nlm.nih.gov/31851632/.
Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006; 44(1): 124–31. https://pubmed.ncbi.nlm.nih.gov/16390959/.
Brik A, Terrade A, Hong E, Deghmane A, Taha MK, Bouafsoun A, et al. Phenotypic and genotypic characterization of meningococcal isolates in Tunis, Tunisia: high diversity and impact on vaccination strategies. Int J Infect Dis 2020; 91: 73–8. https://pubmed.ncbi.nlm.nih.gov/31756567/.
Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23(3): 467–92. https://pubmed.ncbi.nlm.nih.gov/20610819/.
Swanson D. Meningitis. Pediatr Rev 2015; 36(12): 514–24. https://pubmed.ncbi.nlm.nih.gov/26628732/.
Ulanova M, Tsang RSW. Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect Genet Evol 2009; 9(4): 594–605. https://pubmed.ncbi.nlm.nih.gov/19460326/.
van de Beek D, Brouwer M, Hasbun R, Koedel U, Whitney CG, Wijdicks E. Community-acquired bacterial meningitis. Nat Rev Dis Primer 2016; 2: 16074. https://pubmed.ncbi.nlm.nih.gov/27808261/.
Russo DO, Torres BR, Romanelli RMC, Rocha F de SV, Viegas ECC, Diniz LM de O. Haemophilus influenzae serotype a as a cause of meningitis in children in Brazil. Pediatr Infect Dis J 2022; 41(2): 108–11. https://pubmed.ncbi.nlm.nih.gov/35017451/.
Wen S, Feng D, Chen D, Yang L, Xu Z. Molecular epidemiology and evolution of Haemophilus influenzae. Infect Genet Evol 2020; 80: 104205. https://pubmed.ncbi.nlm.nih.gov/31981610/.
Oueslati S, Smaoui H, Joubert G, Dabernat H, Kechrid A. Beta lactam resistance and molecular markers of 157 Haemophilus influenzae isolates from infants in Tunis. Can J Microbiol 2009; 55(5): 515–9. https://pubmed.ncbi.nlm.nih.gov/19483779/.
Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009; 360(3): 244–56. https://pubmed.ncbi.nlm.nih.gov/19144940/.
Steens A, Bergsaker MAR, Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine 2013; 31(52): 6232–8. https://pubmed.ncbi.nlm.nih.gov/24176490/.
Casado-Flores J, Aristegui J, de Liria CR, Martinón JM, Fernández C, Spanish Pneumococcal Meningitis Study Group. Clinical data and factors associated with poor outcome in pneumococcal meningitis. Eur J Pediatr 2006; 165(5): 285–9. https://pubmed.ncbi.nlm.nih.gov/16333641/.
Thabet F, Tilouche S, Tabarki B, Amri F, Guediche MN, Sfar MT, et al. Pneumococcal meningitis mortality in children: prognostic factors in a serie of 73 cases. Arch Pediatr 2007; 14(4): 334–7. https://pubmed.ncbi.nlm.nih.gov/17187969/.
Isturiz R, Sings HL, Hilton B, Arguedas A, Reinert RR, Jodar L. Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert Rev Vaccin 2017; 16(10): 1007–27. https://pubmed.ncbi.nlm.nih.gov/28783380/.
Imöhl M, Möller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany. BMC Infect Dis 2015; 15: 61. https://pubmed.ncbi.nlm.nih.gov/25885764/.
Bingen E. Role of pneumococcus in pediatric infectious pathology. Pathol Biol 2002; 50(6): 374–9. https://pubmed.ncbi.nlm.nih.gov/12168255/.
Varon E, Batah J. Rapport d’activité du Centre National de Référence du Pneumocoque Epidémiologie 2018–2019. France. IOP Publishing Physics Web; 2020. 88 p. http://www.https://cnr-pneumo.com/docman/rapports/46-2020-epidemiologie-2018-2019/file. Accessed 14 May 2022.
Taha MK, Presa J, Serra L. A review of the epidemiology of invasive meningococcal disease and vaccination strategies in North Africa. Int J Infect Dis 2021; 104: 189–97. https://pubmed.ncbi.nlm.nih.gov/33227521/.
Smaoui H, Saguer A, Bouziri A, Fourati S, Chahed MK, Ben Jaballah N, et al. Neisseria meningitidis invasive infections in children in Tunis: about 79 cases. Arch Inst Pasteur Tunis 2011; 88(1–4): 35–41. https://pubmed.ncbi.nlm.nih.gov/23461141/.
Tzanakaki G, Mastrantonio P. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region. Int J Antimicrob Agents 2007; 29(6): 621–9. https://pubmed.ncbi.nlm.nih.gov/17368858/.
Saguer A, Smaoui H, Taha MK, Kechrid A. Characterization of invasive Neisseria meningitidis strains isolated at the Children’s Hospital of Tunis, Tunisia. East Mediterr Health J 2016; 22(5): 343–9. https://pubmed.ncbi.nlm.nih.gov/27553401/.
Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. The Cochrane Database Syst Rev 2006; 18: CD004785. Available from: https://pubmed.ncbi.nlm.nih.gov/17054214/.
Trestioreanu AZ, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev 2013; 10: CD004785. https://pubmed.ncbi.nlm.nih.gov/24163051/.